| Document |
Document Title |
|
WO/2010/143700A1 |
Disclosed is a method whereby oseltamivir can be safely and stably produced in a large amount, via a dihydroxyhexenoic acid ester represented by formula (1), by using tartaric acid, mannitol or arabinose as a starting material. In formul...
|
|
WO/2010/143734A1 |
Disclosed is a method whereby oseltamivir can be safely and stably produced in a large amount, via a nitro group-containing ether compound represented by formula (1), by using tartaric acid, mannitol or arabinose as a starting material. ...
|
|
WO/2010/144055A1 |
The invention relates to compounds represented by the general formula (I): and pharmaceutically acceptable salts thereof, wherein n is an integer from 1 to 5; p is an integer from 0 to 4; R1 is selected from the group consisting of a hyd...
|
|
WO/2010/138484A2 |
The present invention relates to a process of providing the 3 -(6-(I -(2,2- difluorobenzo[d][l,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2- yl)benzoic acid in substantially free form (Compound 1).
|
|
WO/2010/136506A1 |
The present invention concerns 4-fluoro-4-R-5-R'-1,3-dioxolane-2-ones, wherein R is an alkyl group and R' is H or a C1 to C3 alkyl group, their manufacture, solvent mixtures for lithium ion batteries containing them and conductive salt s...
|
|
WO/2010/136037A1 |
The invention relates to novel calcium-sensing receptor (CaSR) modulating substituted cyclopentylene compounds represented in formula I and derivatives thereof, to said compounds for use as a medicament, to said compounds for use in ther...
|
|
WO/2010/131274A1 |
A process is described for preparing hydrocinnamic aldehydes in enantiopure or enantiomerically enriched form of Formula I, in which R is isopropyl or tert-butyl and R' is hydrogen, or R and R' when taken together are a methylenedioxolyl...
|
|
WO/2010/128634A1 |
A novel process for producing a 4,5-dialkyl-4,5-difluoro-1,3-dioxolan-2-one, characterized by reacting a 4,5-dialkyl-1,3-dioxolan-2-on-4,5-ene with a fluorinating agent.
|
|
WO/2010/126811A1 |
The present invention relates to compounds of formula (I), and pharmaceutically acceptable salts thereof, wherein R1 to R5, A, B, D and X are as defined herein. The invention also relates to pharmaceutical compositions comprising these c...
|
|
WO/2010/125134A1 |
The present invention relates to N-phenyl-(piperazinyl or homopiperazinyl)- benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds,pharmaceutical compositions containing them, and their use in therapy. The ...
|
|
WO/2010/123139A1 |
Disclosed is a long-chain fatty acid elongase (Elovl6) inhibitor, which is characterized by comprising at least one of a compound represented by formula (I), a pharmaceutically acceptable salt of the compound, and a solvate of the compou...
|
|
WO/2010/123016A1 |
Disclosed is a compound having a GPR40 agonistic activity and useful for use in a pharmaceutical composition or useful as an insulin secretion promoter or a prophylactic or therapeutic agent for diabetes. Extensive studies have been made...
|
|
WO/2010/124201A2 |
Ortho methoxy phenolic compounds are provided that include methylenedioxyphenyl ferulate and ferulylproline and derivatives thereof. Pharmaceutical compositions comprising the compounds and methods of using the compounds for treating car...
|
|
WO/2010/122968A1 |
Disclosed is a compound useful as an anti-obesity agent. Studies have been made on compounds which have a DGAT1 inhibitory activity and are therefore promising active ingredients for pharmaceutical compositions for treating obesity, type...
|
|
WO/2010/122239A1 |
The invention relates to compounds of the formula (I) having a physiological effect, and to the preparation thereof and to the use of the same.
|
|
WO/2010/122451A1 |
The present invention relates to the field of perfumery. More particularly, it concerns some acetal derivatives of 2,2,3, 6-tetramethyl-1-cyclohexane/ene-carbaldehyde of formula (I) wherein one dotted line indicates the presence of a car...
|
|
WO/2010/119890A1 |
Disclosed is a method for producing a tetrahydropyran compound represented by general formula (5) shown in the scheme. Accordingly, a tetrahydropyran derivative is obtained in high yield and with high selectivity without using a highly t...
|
|
WO/2010/117040A1 |
Disclosed is a compound having excellent FATP4 inhibitory activity. Specifically disclosed is a five-membered heterocyclic compound represented by formula (I) or a pharmaceutically acceptable salt thereof. In formula (I), A represents -C...
|
|
WO/2010/116342A2 |
The present invention concerns compounds of general Formula (I) : method of preparation and uses thereof.
|
|
WO/2010/112211A1 |
The present invention relates to a method for producing biphenyl compounds substituted in the ring. The method can be performed in a cost-effective manner and provides good regioselectivity. Functionalized biphenyl compounds are of great...
|
|
WO/2010/113813A1 |
Disclosed are: a base-generating agent which has a high sensitivity and a wide application range; and a photosensitive resin composition which has a wide range of application choices owing to the structure of a polymer precursor the reac...
|
|
WO/2010/108856A1 |
Provided herein are compounds of the formula (I) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing ...
|
|
WO/2010/108903A1 |
The present invention relates to compounds of formula (I), wherein R1a to R1e, R2, R3 and R5 are as defined in the description and claims and R4 signifies a bicyclic heteroaryl group or a cyanophenyl group, as well as pharmaceutically 5 ...
|
|
WO/2010/106324A1 |
Dimeric aluminium catalysts of formula I: and their use in catalysing the synthesis of cyclic carbonates from epoxides and carbon dioxide.
|
|
WO/2010/103297A2 |
There is provided compounds of formula (I), wherein Y, ring A1 D1, D2a, D2b, D3, L1, Y1, L3 and Y3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of dise...
|
|
WO/2010/103279A1 |
There is provided compounds of formula I, wherein Y, ring A, Da, Db, D2, D3, L1, Y1, L2, Y2, L3 and Y3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of ...
|
|
WO/2010/099573A1 |
The invention provides a compound including : A core having a first face and a second face; A binding portion attached to the first face of the core, wherein the binding portion is capable of binding to an anionic group present in a cell...
|
|
WO/2010/097811A1 |
The present invention provides a process for the preparation of some novel 2-aryl and 2,2-diaryl aldehydes and analogues which are privileged intermediates for commercially important nonsteroidal anti-inflammatory drugs including naproxe...
|
|
WO/2010/097585A1 |
A method of making an organic carbonate compound or sulphur analogue thereof is provided, the method comprising reacting urea (or a urea derivative or analogue) with an organic compound comprising at least one group selected from hydroxy...
|
|
WO/2010/096677A2 |
Compounds are provided that comprise dinitroso-derivatives of dihydrolipoic acid. Pharmaceutical compositions comprising the compounds and methods of using the compounds for treating various diseases and disorders, including angina, hype...
|
|
WO/2010/091540A1 |
A sulphonyl tetrazole compound 7 with the following structure, its preparation method and its use for preparing laetispicine. The said sulphonyl tetrazole compound 7, (1-phenyl-5-(3,4-methylenedioxyphenyl ethyl) sulphonyl tetrazole), is ...
|
|
WO/2010/089264A1 |
The invention relates to a method for producing compounds having at least two alkylene carbonate groups (referred to as alkylene carbonate for short) by reacting a compound having at least two alkylene oxide groups (referred to as alkyle...
|
|
WO/2010/090304A1 |
Disclosed is an excellent agent for treatment or prevention of dementia, schizophrenia and the like, which has a serotonin 5-HT5A receptor modulating activity. An acylguanidine derivative represented by formula (I), wherein guanidine is ...
|
|
WO/2010/086366A1 |
The invention relates to compound of the formula (I) in which the substituents are as defined in the specification; m free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
|
|
WO/2010/087430A1 |
An N-acyl anthranilic acid derivative represented by general formula (I) or a salt thereof is useful for prevention or treatment of diseases associated with excessive production of collagen. (In the formula, R1 represents a carboxyl grou...
|
|
WO/2010/085377A2 |
The disclosure includes hydroxamic compounds of Formula I: (I) wherein P, Z, and m are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compounds.
|
|
WO/2010/084997A1 |
Provided is a polyfunctional polymer having high stereoregularity, particularly isotacticity, chemical modifications thereof, and a method for producing the same. The molecules of the polymer have repeating units represented by general f...
|
|
WO/2010/079423A1 |
The present invention relates to compounds of general formula 1 for the treatment of malignancy by inhibition of PI3-Akt pathway and or induction of NO. The present invention also relates to the use of compound of general formula 1 for t...
|
|
WO/2010/075330A1 |
Disclosed herein are ketal amide compounds. The ketal amide compounds are synthesized by the reaction of ketal acids or ketal esters with amine functional compounds. Also disclosed are methodologies useful to make the ketal amide compoun...
|
|
WO/2010/074327A1 |
There is provided a halogen-containing organosulfur compound having a controlling effect on arthropod pests represented by the formula (I): wherein m represents 0, 1 or 2; n represents 0, 1 or 2; A represents an optionally substituted 3-...
|
|
WO/2010/069893A1 |
The invention provides a container containing a fluorinated organic carbonate and a gas atmosphere which contains cover gas selected from the group consisting of a noble gas, e.g., argon, xenon, a gaseous fluorinated aliphatic carbon whi...
|
|
WO/2010/067442A1 |
Disclosed is a practical method for efficiently producing an alcohol compound by hydrogenating an aldehyde by using a homogeneous copper catalyst which is an easily-available low-cost metal species. Specifically disclosed is a method for...
|
|
WO/2010/067627A1 |
A compound represented by R-X, wherein R is a group represented by formula (1) and X is a halogen atom, hydroxy, an aryloxy, or a (meth)acrylic ester group represented by formula (5).
|
|
WO/2010/064158A1 |
The present invention relates to the field of perfumery. More particularly, it concerns some acetal derivatives of 3-methyl citral of formula (I) wherein the dotted lines indicate the presence of a single or double bond; R1 represents a ...
|
|
WO/2010/065512A2 |
The present invention is directed to compounds represented by structural formula (I), or a pharmaceutically acceptable salt or a transition metal chelate, coordinate or complex thereof or a transition metal chelate, coordinate or complex...
|
|
WO/2010/055005A1 |
The invention is concerned with the compounds of formula (I) and pharmaceutically acceptable salts and esters thereof, wherein X, Q, and R1-R6 are defined in the detailed description and claims. In addition, the present invention relates...
|
|
WO/2010/056020A2 |
The present invention relates to a lithium secondary battery comprising a negative pole for absorbing and discharging lithium ions, a positive pole made of a lithium-containing oxide, and a non-aqueous electrolytic solution. Said lithium...
|
|
WO/2010/053583A2 |
The invention provides for compounds of formula I: wherein Z is absent or (CRARB)nW; each RA and RB is independently (i) H, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, haloalkyl, each ...
|
|
WO/2010/054158A2 |
The present invention relates to new steroid modulators of glucocorticoid receptor activity, pharmaceutical compositions thereof, and methods of use thereof.
|
|
WO/2010/046194A1 |
Cyclohexanedione compounds, which are suitable for use as herbicides.
|
